Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-10-14

Clinical Trial Update: Can Methylnaltrexone Safely Treat Opioid Related Constipation in the Emergency Department? [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating methylnaltrexone for opioid-related constipation in the emergency department has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylnaltrexone (methylnaltrexone)

Snippet

Sponsor: Beth Israel Medical Center | Conditions: Colonic Inertia | Phase 4 | Status: WITHDRAWN